These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 25384570)

  • 41. Testosterone replacement therapy: who to evaluate, what to use, how to follow, and who is at risk?
    Afiadata A; Ellsworth P
    Hosp Pract (1995); 2014 Dec; 42(5):69-82. PubMed ID: 25485919
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Double-blind placebo-controlled study of testosterone patch therapy on bone turnover in men with borderline hypogonadism.
    Merza Z; Blumsohn A; Mah PM; Meads DM; McKenna SP; Wylie K; Eastell R; Wu F; Ross RJ
    Int J Androl; 2006 Jun; 29(3):381-91. PubMed ID: 16390499
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Is androgen therapy indicated in men with osteoporosis?
    Hoppé E; Bouvard B; Royer M; Chappard D; Audran M; Legrand E
    Joint Bone Spine; 2013 Oct; 80(5):459-65. PubMed ID: 23587643
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Italian Society of Endocrinology Consensus Statement: definition, evaluation and management of patients with mild primary hyperparathyroidism.
    Marcocci C; Brandi ML; Scillitani A; Corbetta S; Faggiano A; Gianotti L; Migliaccio S; Minisola S
    J Endocrinol Invest; 2015 May; 38(5):577-93. PubMed ID: 25820553
    [No Abstract]   [Full Text] [Related]  

  • 45. [Bone and Men's Health. Androgen replacement therapy and bone metabolism].
    Ogawa S
    Clin Calcium; 2010 Feb; 20(2):251-7. PubMed ID: 20118518
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Androgen replacement therapy in Turner syndrome: a pilot study.
    Zuckerman-Levin N; Frolova-Bishara T; Militianu D; Levin M; Aharon-Peretz J; Hochberg Z
    J Clin Endocrinol Metab; 2009 Dec; 94(12):4820-7. PubMed ID: 19846743
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Testosterone replacement therapy: improved sexual desire and erectile function in men with type 2 diabetes following a 30-week randomized placebo-controlled study.
    Hackett G; Cole N; Saghir A; Jones P; Strange RC; Ramachandran S
    Andrology; 2017 Sep; 5(5):905-913. PubMed ID: 28771964
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Commentary: Guideline for male testosterone therapy: a clinician's perspective.
    Morgentaler A
    J Clin Endocrinol Metab; 2007 Feb; 92(2):416-7. PubMed ID: 17284642
    [No Abstract]   [Full Text] [Related]  

  • 49. Endocrine aspects of sexual dysfunction in men.
    Morales A; Buvat J; Gooren LJ; Guay AT; Kaufman JM; Tan HM; Torres LO
    J Sex Med; 2004 Jul; 1(1):69-81. PubMed ID: 16422986
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Commentary: Guideline for male testosterone therapy: a European perspective.
    Wu FC
    J Clin Endocrinol Metab; 2007 Feb; 92(2):418-9. PubMed ID: 17284643
    [No Abstract]   [Full Text] [Related]  

  • 51. 12-month observation of testosterone replacement effectiveness in a general population of men.
    Miner MM; Bhattacharya RK; Blick G; Kushner H; Khera M
    Postgrad Med; 2013 Mar; 125(2):8-18. PubMed ID: 23816767
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of long-term testosterone replacement therapy, with a temporary intermission, on glycemic control of nine hypogonadal men with type 1 diabetes mellitus - a series of case reports.
    Saad F; Yassin A; Almehmadi Y; Doros G; Gooren L
    Aging Male; 2015; 18(3):164-8. PubMed ID: 26075537
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Androgen receptor gene CAG repeat polymorphism independently influences recovery of male sexual function after testosterone replacement therapy in postsurgical hypogonadotropic hypogonadism.
    Tirabassi G; Delli Muti N; Corona G; Maggi M; Balercia G
    J Sex Med; 2014 May; 11(5):1302-8. PubMed ID: 24593124
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of testosterone on body composition, bone metabolism and serum lipid profile in middle-aged men: a meta-analysis.
    Isidori AM; Giannetta E; Greco EA; Gianfrilli D; Bonifacio V; Isidori A; Lenzi A; Fabbri A
    Clin Endocrinol (Oxf); 2005 Sep; 63(3):280-93. PubMed ID: 16117815
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Testosterone therapy: where do the latest guidelines agree and differ?
    Pelzman DL; Hwang K
    Curr Opin Endocrinol Diabetes Obes; 2020 Dec; 27(6):397-403. PubMed ID: 33044244
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Physicians' attitudes towards androgen replacement therapy for male and female sexual dysfunction.
    Lowenstein L; Shechter A; Porst H; Tripodi F; Reisman Y
    Int J Impot Res; 2016; 28(2):57-60; quiz 60-1. PubMed ID: 26865099
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Injection of testosterone may be safer and more effective than transdermal administration for combating loss of muscle and bone in older men.
    Borst SE; Yarrow JF
    Am J Physiol Endocrinol Metab; 2015 Jun; 308(12):E1035-42. PubMed ID: 25898953
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Androgen deficiency in the aging male: a guide to diagnosis and testosterone replacement therapy.
    Raynor MC; Carson CC; Pearson MD; Nix JW
    Can J Urol; 2007 Dec; 14 Suppl 1():63-8. PubMed ID: 18163948
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of testosterone supplementation on depressive symptoms and sexual dysfunction in hypogonadal men with the metabolic syndrome.
    Giltay EJ; Tishova YA; Mskhalaya GJ; Gooren LJ; Saad F; Kalinchenko SY
    J Sex Med; 2010 Jul; 7(7):2572-82. PubMed ID: 20524974
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Testosterone replacement therapy does not promote priapism in hypogonadal men with sickle cell disease: 12-month safety report.
    Morrison BF; Reid M; Madden W; Burnett AL
    Andrology; 2013 Jul; 1(4):576-82. PubMed ID: 23606509
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.